Skip to main content
Top

Drugs

Issue 10/2025

Content (11 Articles)

Pharmacotherapy for Autoimmune Pulmonary Alveolar Proteinosis

Stéphane Jouneau, Pierre Chauvin, Mathieu Lederlin, Benoît Painvin, Mallorie Kerjouan

Update on Medical Treatment of Cushing’s Syndrome

Brendan R. Dillon, Nidhi Agrawal, Yair Schwarz, Kristen Dancel-Manning, Antoine Tabarin, André Lacroix, Leo J. Hofland, Richard A. Feelders

Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy

Jennifer H. Cooperrider, Benjamin A. Derman

Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management

Athena Philis-Tsimikas, Jens Aberle, Harpreet Bajaj, Ildiko Lingvay, Yiming Mu, Shehla Shaikh, André Vianna, Hirotaka Watada, Stefano Del Prato

Current Evidence on Celecoxib Safety in the Management of Chronic Musculoskeletal Conditions: An Umbrella Review

Charlotte Beaudart, Christian Brabant, Majed Alokail, Jean-Yves Reginster, Olivier Bruyère

Acoltremon: First Approval

Arnold Lee

Atrasentan: First Approval

Susan J. Keam

Avutometinib and Defactinib: First Approval

  • NSCLC
  • AdisInsight Report

Hannah A. Blair

Linvoseltamab: First Approval

Arnold Lee